Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Physiological Study to Predict Successful Sleep Apnea Treatment With Acetazolamide in Heart Failure Patients

NCT01377987 is registered in ClinicalTrials.gov with David Andrew Wellman as lead sponsor.

NCT NCT01377987
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01377987 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Physiological Study to Predict Successful Sleep Apnea Treatment With Acetazolamide in Heart Failure Patients
Lead sponsor
David Andrew Wellman
Phase
Not applicable
Overall status
Completed
Start date
August 31, 2011
Completion date
December 31, 2016
Enrollment
29 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heart failures